GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related ...

Ubisoft's failed Call of Duty rival XDefiant has received a hefty final update today, December 18, ahead of its shutdown in 2025.

But, increased costs became a drag on net income in 2023 as firms invested in technology and infrastructure. Further ...

XDefiant is a free-to-play, fast-paced arena shooter that combines intense gunplay with personalized loadouts and specialized factions, as teams of gunfighters – called Defiants – battle for ...